Mar 25, 2022|
JD Health to Promote Chinese Consumers’ Access to FSMP
by Vivian Yang
JD Health has been expanding supplies and services on foods for special medical purposes (FSMP) to make them more accessible and affordable for Chinese consumers via the internet, said Ye Yang, general manager of the nutrition and healthcare department of JD Health during a webcast discussion on the topic of FSMP’s innovations and role in promoting health in China held by People’s Daily in Beijing on March 13th.
FSMP are intended to provide nutritional support to people who suffer from a specific disease, disorder or a medical condition, as a part of their dietary management. In recent years, Chinese policies such as the National Nutrition Plan (2017-2030) have put forward clear requirements for promoting FSMP and its application standards. It has also drawn increasing attention among the larger public, especially because of its value for the elderly, infants, pregnant women and patients who have special nutrition needs.
JD Health is China’s online channel that offers the most comprehensive FSMP categories, with 41 products available for online sales so far that have been approved on the Chinese market and are suitable for home use.
Nutrition-related content on JD Health’s online hospital
JD Health’s data shows that 92 percent of users wished to receive professional guidance on healthcare advice and product usage when they look for FSMP products online. Thus an “Ask a Doctor” tab is embedded in JD’s products’ pages where users can directly interact with doctors or nutritionists to get real-time support. Users can also go to the dedicated portal of the nutrition department under JD Health’s online hospital for more comprehensive knowledge and consultations.
JD Health launched customized Family Doctor telemedicine service for FSMP users
Last October, JD Health introduced seven customized Family Doctor services for FSMP users, focusing on providing personalized telemedicine services for allergy-prone infants, malnourished infants, patients after tumor surgeries, and more special groups of users.